AI assistant
DBV Technologies S.A. — Director's Dealing 2023
Nov 22, 2023
33512_dirs_2023-11-22_7f01abaa-6601-485f-8679-aef661796a53.zip
Director's Dealing
Open in viewerOpens in your device viewer
SEC Form 4 — Statement of Changes in Beneficial Ownership
Issuer: DBV Technologies S.A. (DBVT)
CIK: 0001613780
Period of Report: 2023-11-20
Reporting Person: Mohideen Pharis (Chief Medical Officer)
Non-Derivative Transactions
| Date | Security | Code | Shares | Price | A/D | Holdings After | Ownership |
|---|---|---|---|---|---|---|---|
| 2023-11-20 | Ordinary Shares | A | 35000 | $0.00 | Acquired | 84439 | Direct |
Derivative Transactions
| Date | Security | Exercise Price | Code | Shares | A/D | Expiration | Underlying | Ownership |
|---|---|---|---|---|---|---|---|---|
| 2023-11-20 | Employee Stock Option (right to buy) | $2.19 | A | 215000 | Acquired | 2033-11-20 | Ordinary Shares (215000) | Direct |
Footnotes
F1: Represents the Issuer's ordinary shares underlying a restricted stock unit ("RSU") award. Each RSU represents a contingent right to receive one ordinary share. The RSUs shall vest in four equal annual installments commencing on November 20, 2024, subject to the Reporting Person continuing to provide service through each such date.
F2: This exercise price is in US Dollars and reflects the conversion of EURO to USD at an exchange rate of $1.0928 to EURO 1.00 as of November 20, 2023.
F3: The option shall vest in four equal annual installments commencing on November 20, 2024, subject to the Reporting Person continuing to provide service through each such date.